RE: Trader8 Apr 2016 13:04
I was in shock when I saw another post. There was 2 new ones the other day but somebody posted here by mistake and they were removed. Agreed with the boredom. If this was say 2.55-2.65p with 10 times more shares in issue there would be regular trades and lots of posts and holders. It really is off the menu but I hold waiting for that Rns soon of a surprise price for the Fresh business then everybody will be trying to buy in when 30-50% higher, well that is my take on it. The large director buy at 28p gives me condifence, can only assume the selling afterwards was end of tax year.
If you check website there is 2 products almost ready for clinical trials, it's amazing what a Rns for those to start will do to a price although not as exciting as SAR's cancer products. All backed by high cash levels. I cannot see the downside.....all boxes ticked just a big dose of patience